gvtcx

NP Generic Medicines Transition Tender (October 2023)

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£4,972,000
Statuscomplete
Category (CPV) 33600000
RegionScotland
Deadline14 Aug 2023
Procedureopen
OCIDocds-h6vhtk-03e1fc

Awards (7)

This procurement was awarded to 7 suppliers. Values shown are per-award; the notice total is £4,972,000.

SupplierValueDateStatus
Celix Pharma Ltd. shared · · active
Dr Reddy's Laboratories (UK) Ltd shared · · ·
Glenmark Pharmaceuticals Europe Ltd shared · · ·
Selective Supplies Ltd shared · · active
Teva UK Ltd shared · · active
Thornton & Ross shared · · active
Viatris UK Healthcare Ltd shared · · active

description

This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
14 Jul 2023 Contract notice (F02) Earlier regulations 020286-2023
26 Sept 2023 Contract award notice (F03) Earlier regulations 028388-2023

more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.